Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Vanda Pharmaceuticals (VNDA) Return on Capital Employed (2016 - 2025)

Vanda Pharmaceuticals' Return on Capital Employed history spans 14 years, with the latest figure at 0.38% for Q4 2025.

  • For Q4 2025, Return on Capital Employed fell 30.0% year-over-year to 0.38%; the TTM value through Dec 2025 reached 0.38%, down 30.0%, while the annual FY2025 figure was 0.35%, 28.0% down from the prior year.
  • Return on Capital Employed for Q4 2025 was 0.38% at Vanda Pharmaceuticals, down from 0.24% in the prior quarter.
  • Across five years, Return on Capital Employed topped out at 0.09% in Q3 2021 and bottomed at 0.38% in Q4 2025.
  • The 5-year median for Return on Capital Employed is 0.01% (2022), against an average of 0.04%.
  • The largest annual shift saw Return on Capital Employed rose 4bps in 2021 before it dropped -30bps in 2025.
  • A 5-year view of Return on Capital Employed shows it stood at 0.08% in 2021, then plummeted by -86bps to 0.01% in 2022, then tumbled by -312bps to 0.03% in 2023, then crashed by -195bps to 0.07% in 2024, then tumbled by -412bps to 0.38% in 2025.
  • Per Business Quant, the three most recent readings for VNDA's Return on Capital Employed are 0.38% (Q4 2025), 0.24% (Q3 2025), and 0.2% (Q2 2025).